GetTopicDetailResponse(id=c0501084e91d, topicName=貝福替尼, introduction=貝福替尼, content=非小細胞肺癌 EGFR 埃克替尼 貝福替尼, image=null, comments=0, allHits=1369, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Dec 11 10:25:32 CST 2023, time=2023-12-11, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=476362, tagList=[TagDto(tagId=476362, tagName=貝福替尼)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2225092, encodeId=cdb7222509203, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細胞肺癌#</a> <a href='/topic/show?id=c0501084e91d' target=_blank style='color:#2F92EE;'>#貝福替尼#</a>, objectTitle=連線WCLC | 凱賽攜手靶向耐藥新策略，重磅數(shù)據(jù)亮相2024 WCLC, objectType=article, longId=842618, objectId=e0088426180d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240709/1720503095993_8538692.jpg, objectUrl=/article/show_article.do?id=e0088426180d, replyNumber=0, likeNumber=73, createdTime=2024-09-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e0088426180d, moduleTitle=連線WCLC | 凱賽攜手靶向耐藥新策略，重磅數(shù)據(jù)亮相2024 WCLC, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e0088426180d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225100, encodeId=d1052225100e4, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a> <a href='/topic/show?id=c0501084e91d' target=_blank style='color:#2F92EE;'>#貝福替尼#</a>, objectTitle=2024WCLC揭示IBIO-102研究最新突破：凱賽序貫顯著延長肺癌生存, objectType=article, longId=842628, objectId=dc46842628de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240905/1725498482877_8538692.jpg, objectUrl=/article/show_article.do?id=dc46842628de, replyNumber=0, likeNumber=98, createdTime=2024-09-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=dc46842628de, moduleTitle=2024WCLC揭示IBIO-102研究最新突破：凱賽序貫顯著延長肺癌生存, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dc46842628de)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221679, encodeId=5e1122216e97f, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細胞肺癌#</a> <a href='/topic/show?id=c0501084e91d' target=_blank style='color:#2F92EE;'>#貝福替尼#</a>, objectTitle=從試驗數(shù)據(jù)到臨床實戰(zhàn)：貝福替尼II期最終總生存率見刊Lung Cancer, objectType=article, longId=839982, objectId=adc7839982dd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720668862484_5579292.png, objectUrl=/article/show_article.do?id=adc7839982dd, replyNumber=0, likeNumber=228, createdTime=2024-08-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=adc7839982dd, moduleTitle=從試驗數(shù)據(jù)到臨床實戰(zhàn)：貝福替尼II期最終總生存率見刊Lung Cancer, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=adc7839982dd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174227, encodeId=263021e422787, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細胞肺癌#</a> <a href='/topic/show?id=4c496569c8' target=_blank style='color:#2F92EE;'>#EGFR#</a> <a href='/topic/show?id=011941548ad' target=_blank style='color:#2F92EE;'>#?？颂婺?</a> <a href='/topic/show?id=c0501084e91d' target=_blank style='color:#2F92EE;'>#貝福替尼#</a>, objectTitle=貝家講壇 | 聚焦腦轉(zhuǎn)移與共突變?nèi)巳?，原研EGFR-TKI貝福替尼與埃克替尼先「卷」為敬, objectType=article, longId=804440, objectId=cc00804440fd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021554762_4754896.jpeg, objectUrl=/article/show_article.do?id=cc00804440fd, replyNumber=0, likeNumber=166, createdTime=2023-12-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=cc00804440fd, moduleTitle=貝家講壇 | 聚焦腦轉(zhuǎn)移與共突變?nèi)巳?，原研EGFR-TKI貝福替尼與?？颂婺嵯取妇怼篂榫? moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cc00804440fd)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2023-12-11發(fā)表于上海
